Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

Summary

The purpose of this study is to examine the drug-drug interaction when given the study drug, bexagliflozin, with one of the most commonly prescribed glucagon-like peptide 1 receptor agonist (GLP-1 RA) exenatide. The study will also evaluate how safe the study drug is and how well the study drug is tolerated when administered with exenatide injection.

Timeline

Start

2017-05-24

Primary completion

2017-06-29

Completion

2017-06-29

Drugs

Indications